American International Group, Inc. Curis Inc Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $30,529 - $104,487	-42,999 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.31 - $5.13 $6,992 - $15,528	-3,027 Reduced 6.58%	42,999 $102,000
Q4 2021 Feb 11, 2022	SELL	$4.45 - $8.09 $6,123 - $11,131	-1,376 Reduced 2.9%	46,026 $219,000
Q3 2021 Nov 12, 2021	SELL	$6.94 - $8.85 $7,821 - $9,973	-1,127 Reduced 2.32%	47,402 $371,000
Q2 2021 Aug 13, 2021	BUY	$7.45 - $16.27 $361,541 - $789,566	48,529 New	48,529 $392,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $332M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.